218 related articles for article (PubMed ID: 6086410)
1. Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart.
Brown JH; Masters SB
Fed Proc; 1984 Aug; 43(11):2613-7. PubMed ID: 6086410
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic stimulation of phosphatidylinositol metabolism in atria.
Brown SL; Brown JH
Mol Pharmacol; 1983 Nov; 24(3):351-6. PubMed ID: 6633501
[TBL] [Abstract][Full Text] [Related]
3. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
Brown JH; Goldstein D
Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810
[TBL] [Abstract][Full Text] [Related]
4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
Brown JH; Goldstein D; Masters SB
Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic inhibition of catecholamine-stimulable cyclic AMP accumulation in murine atria.
Brown JH
J Cyclic Nucleotide Res; 1979 Dec; 5(6):423-33. PubMed ID: 231610
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
[TBL] [Abstract][Full Text] [Related]
8. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
Ray A; MacLeod KM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI
J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of phosphoinositide hydrolysis and inhibition of cyclic AMP formation by muscarinic agonists in developing chick heart.
Orellana SA; Brown JH
Biochem Pharmacol; 1985 Apr; 34(8):1321-4. PubMed ID: 2986642
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
Champion S; Mauchamp J
Mol Pharmacol; 1982 Jan; 21(1):66-72. PubMed ID: 6290866
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
McKinney M; Stenstrom S; Richelson E
Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
[TBL] [Abstract][Full Text] [Related]
13. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
Harden TK; Heng MM; Brown JH
Mol Pharmacol; 1986 Sep; 30(3):200-6. PubMed ID: 3018476
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
[TBL] [Abstract][Full Text] [Related]
15. Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes.
Ye C; Sowell MO; Vassilev PM; Milstone DS; Mortensen RM
J Mol Cell Cardiol; 1999 Sep; 31(9):1771-81. PubMed ID: 10471359
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the muscarinic receptors mediating phosphoinositide hydrolysis in rat myometrium.
Varol FG; Hadjiconstantinou M; Zuspan FP; Neff NH
J Pharmacol Exp Ther; 1989 Apr; 249(1):11-5. PubMed ID: 2540309
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
Evans T; Smith MM; Tanner LI; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
[TBL] [Abstract][Full Text] [Related]
18. Effects of the cyclic GMP lowering agent LY83583 on the interaction of carbachol with forskolin in rabbit isolated cardiac preparations.
MacLeod KM; Diamond J
J Pharmacol Exp Ther; 1986 Jul; 238(1):313-8. PubMed ID: 3014120
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
McKinney M; Richelson E
Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic receptors in mammalian myocardium: effects of atrial and ventricular receptors on phosphatidylinositol metabolism and adenylate cyclase.
Ransnäs L; Gjörstrup P; Hjalmarson A; Sjögren CG; Jacobsson B
J Mol Cell Cardiol; 1986 Aug; 18(8):807-14. PubMed ID: 3018267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
